Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3,020.00    -155.00 (-4.88%)
Bid:
3,049.00
Ask:
3,051.00
Spread: 2.00 (0.066%)
Market Cap: £4.21b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Total Voting Rights

30 Jun 2022 12:15

RNS Number : 8550Q
Croda International PLC
30 June 2022
Β 

Croda International Plc

Β 

Β 

Total Voting Rights

Β 

In accordance with Disclosure and Transparency Rule 5.6.1 we notify the market that as at 30 June 2022:

Β 

Croda International Plc's issued share capital consists of 142,536,884 ordinary shares of 10.609756p each of which 2,901,442 ordinary shares are held in treasury.

Β 

Therefore, the total number of voting rights in Croda International Plc is 139,635,442.

Β 

The above figure (139,635,442) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Croda International Plc under the FCA's Disclosure and Transparency Rules.

Β 

Β 

Enquiries:

Β 

Β 

Β 

Tom Brophy

Group General Counsel and Company Secretary

+44 (0)1405 860551

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TVRWPUAGQUPPGGU
Date   Source Headline
1st Nov 20241:44 pmRNSHolding(s) in Company
11th Oct 20242:13 pmRNSDirector/PDMR Shareholding
10th Oct 20243:39 pmRNSDirector/PDMR Shareholding
13th Sep 202410:07 amRNSDirector/PDMR Shareholding
11th Sep 20242:52 pmRNSDirector/PDMR Shareholding
13th Aug 20241:51 pmRNSDirector/PDMR Shareholding
30th Jul 20241:49 pmRNSDirector/PDMR Shareholding - Replacement
30th Jul 20241:40 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSResults for the six months ended 30 June 2024
12th Jul 202411:10 amRNSDirector Declaration
11th Jul 20242:21 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSCroda appoints Chief Financial Officer
25th Jun 202410:00 amRNSDirector/PDMR Shareholding
25th Jun 20247:00 amRNSDirectorate Change
13th Jun 20249:46 amRNSHolding(s) in Company
12th Jun 20249:01 amRNSDirector/PDMR Shareholding
11th Jun 20242:12 pmRNSDirector/PDMR Shareholding
30th May 20243:27 pmRNSDirector/PDMR Shareholding
30th May 20242:33 pmRNSDirector/PDMR Shareholding
13th May 20242:16 pmRNSDirector/PDMR Shareholding
2nd May 20249:27 amRNSDirector/PDMR Shareholding
1st May 202412:18 pmRNSDirector/PDMR Shareholding
25th Apr 202410:01 amRNSResult of AGM
24th Apr 20247:00 amRNSFirst quarter 2024 sales update
11th Apr 20242:11 pmRNSDirector/PDMR Shareholding
8th Apr 202410:54 amRNSDirector/PDMR Shareholding
8th Apr 202410:23 amRNSDirector/PDMR Shareholding
28th Mar 20249:17 amRNSDirector/PDMR Shareholding
26th Mar 20244:19 pmRNSDirector/PDMR Shareholding
26th Mar 20244:10 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSDirector/PDMR Shareholding
26th Mar 20244:06 pmRNSDirector/PDMR Shareholding
26th Mar 20244:04 pmRNSDirector/PDMR Shareholding
15th Mar 20249:32 amRNSAnnual Financial Report
12th Mar 20242:49 pmRNSDirector/PDMR Shareholding
7th Mar 20243:03 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSResults for the year ended 31 December 2023
13th Feb 20243:35 pmRNSDirector/PDMR Shareholding
9th Feb 20243:28 pmRNSHolding(s) in Company
18th Jan 20241:33 pmRNSHolding(s) in Company
11th Jan 20243:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSDirectorate Change
12th Dec 20233:08 pmRNSDirector/PDMR Shareholding
11th Dec 202311:39 amRNSDirector Declaration
29th Nov 20234:54 pmRNSHolding(s) in Company
28th Nov 20239:35 amRNSDirector/PDMR Shareholding
24th Nov 202311:33 amRNSHolding(s) in Company
14th Nov 20239:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.